2m 2m 2m 2m 2m 2m 2m
Selectis Health (GBCS)
OTC
$2.97-$0.11 (-3.70%)
Price as of May 28, 2026- $9.1MMarket Cap
- 96.69%1-Year Change
- Medical Care FacilitiesIndustry
Selectis Health (GBCS)
$2.97-$0.11 (-3.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 39.5M +7.36% | 36.8M -9.40% | 40.6M +38.63% | |
Cost of Revenue | N/A N/A | 42.2M N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 +100.00% | -2.7M -107.42% | 36.8M -9.40% | 40.6M +38.63% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 1.5M -6.09% | 1.6M -5.78% | 1.7M -7.06% | 1.8M +3.43% | |
Total Operating Expenses | 43.0M +1.86% | 42.2M -7.70% | 45.7M +11.88% | 40.9M +36.21% | |
Operating Profit | -1.6M -42.67% | -2.7M -69.54% | -9.0M +3,026.76% | -286,572 -60.69% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 168,458 N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.2M -2.58% | -2.2M -10.68% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -2.2M +5.38% | -2.1M -17.42% | |
Total Nonoperating Income and Expense | 549,719 +80.10% | 305,237 -93.88% | 5.0M +336.55% | -2.1M +39.47% | |
Income before Taxes | -1.0M -58.51% | -2.4M -38.85% | -4.0M +64.93% | -2.4M +6.30% | |
Income Taxes | 800 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.1M -56.95% | -2.4M -38.39% | -4.0M +65.75% | -2.4M +6.39% | |
Net Income from Continuing Operations Applicable to Common | -1.1M -56.95% | -2.4M -38.85% | -4.0M +64.93% | -2.4M +6.30% | |
Basic EPS and Net Income | -0.34 -57.50% | -0.80 -38.93% | -1.31 +65.82% | -0.79 -3.66% | |
Diluted EPS and Net Income | -0.34 -57.50% | -0.80 -38.93% | -1.31 +65.82% | -0.79 -3.66% | |
Basic Weighted Average Shares | 3.1M 0.00% | 3.1M +0.41% | 3.1M +0.02% | 3.1M +10.33% | |
Diluted Weighted Average Shares | 3.1M 0.00% | 3.1M +0.41% | 3.1M +0.02% | 3.1M +10.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.0M +48.70% | 680,332 -54.17% | 1.5M +4.53% | 1.4M -63.95% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.0M +48.70% | 680,332 -54.17% | 1.5M +4.53% | 1.4M -63.95% | |
Total Current Assets | 7.6M +114.79% | 3.5M -28.77% | 5.0M -0.12% | 5.0M -37.72% | |
Accumulated Depreciation | 13.8M -6.82% | 14.9M +7.07% | 13.9M +13.64% | 12.2M +17.21% | |
Property and Plant and Equipment and Net | 23.1M -17.96% | 28.1M -16.82% | 33.8M -4.62% | 35.5M -4.24% | |
Total Long-Term Assets | 23.1M -17.96% | 28.1M -16.82% | 33.8M -4.62% | 35.5M -4.24% | |
Total Assets | 32.6M -2.60% | 33.4M -17.76% | 40.7M -4.28% | 42.5M -9.45% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 12.0M -69.29% | 39.2M +224.77% | 12.1M +277.56% | 3.2M -50.53% | |
Total Current Liabilities | 25.3M +28.77% | 19.6M +8.16% | 18.1M +164.97% | 6.8M -41.90% | |
Total Long-Term Debt | 13.4M -29.92% | 19.1M -24.00% | 25.2M -26.81% | 34.4M +10.76% | |
Total Long-Term Liabilities | 13.4M -29.92% | 19.1M -24.00% | 25.2M -26.81% | 34.4M +10.76% | |
Total Liabilities | 38.8M -0.18% | 38.9M -10.95% | 43.6M +5.05% | 41.5M -5.21% | |
Retained Earnings | -21.2M +5.22% | -20.2M +13.79% | -17.7M +29.11% | -13.7M +21.43% | |
Total Stockholders Equity | -6.2M +14.79% | -5.4M +82.54% | -3.0M -411.05% | 952,835 -69.29% | |
Total Shares Outstanding | 3.1M 0.00% | 3.1M 0.00% | 3.1M +0.41% | 3.1M +1.88% | |
Cash Flow | |||||
Cash from Operating Activities | 1.9M +203.16% | -1.8M -439.96% | 536,666 +275.87% | -305,148 +12.63% | |
Capital Expenditures | 443,611 +1,130.10% | 36,063 +21.00% | 29,805 -86.60% | 222,361 -57.20% | |
Cash from Investing Activities | -443,611 -118.12% | 2.4M +8,315.86% | -29,805 -86.60% | -222,361 -57.20% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -976,692 -36.46% | -1.5M +148.42% | -618,738 -66.54% | -1.8M -215.18% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -6.91% N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -6.91% -71.63% | -24.36% +3,350.94% | -0.71% -71.64% | |
Return on Assets | -3.19% -51.67% | -6.60% -30.87% | -9.55% +78.21% | -5.36% +10.48% | |
Return on Equity | 18.13% -68.98% | 58.43% -85.21% | 394.93% +434.22% | -118.17% +70.96% | |
Revenue Growth | N/A N/A | 7.36% +178.35% | -9.40% -124.34% | 38.63% -3.29% | |
Current Ratio | 0.30 +66.76% | 0.18 -34.15% | 0.27 -62.30% | 0.72 +7.19% | |
Cash Ratio | 0.04 +15.27% | 0.03 -57.58% | 0.08 -60.56% | 0.21 -37.94% | |
Debt-to-Equity Ratio | -4.10 -62.00% | -10.78 -14.21% | -12.57 -131.85% | 39.46 +226.24% | |
Debt-to-Assets Ratio | 0.78 -55.21% | 1.74 +90.45% | 0.92 +3.50% | 0.88 +10.67% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow